MESOF - Overview: Mesothelioma, CDKN2A FISH, Tissue
Supporting the diagnosis of mesothelioma when used in conjunction with an anatomic pathology consultation
AMA - Overview: Mitochondrial Antibodies (M2), Serum
Establishing the diagnosis of primary biliary cholangitis This test is not useful for indicating the stage or prognosis of the disease or for monitoring the course of the disease.
NTRKM - Overview: NTRK Genes Mutation Analysis, Next-Generation Sequencing, Tumor
Identifying NTRK mutations that may predict resistance to Trk inhibitors
PBC2 - Overview: SP100 and GP210 Antibodies, IgG, Serum
Evaluating the risk of primary biliary cholangitis in anti-mitochondrial antibody (AMA)-negative patients by identification of Sp100 and gp210 antibodies Estimating risk in AMA-positive patients with incomplete feature of disease
STER - Overview: Sterols, Plasma
Investigation of possible desmosterolosis (desmosterol reductase deficiency), cerebrotendinous xanthomatosis, lathosterolosis, sitosterolemia, sterol C4 methyl oxidase deficiency, MEND (male EBP disorder with neurologic defects) syndrome,...
FAS1A - Overview: Anti-SAE1 Ab, IgG
Anti-SAE1 Ab, IgG
FRFIT - Overview: Rabies Antibody Endpoint
Rabies Antibody Endpoint
AMH1 - Overview: Antimullerian Hormone, Serum
Assessing ovarian status, including ovarian reserve and responsiveness, as part of an evaluation for infertility and assisted reproduction protocols Assessment of menopausal status, including premature ovarian failure Evaluation of...
HBAGP - Overview: Hepatitis B Virus Surface Antigen Prenatal, Serum
Diagnosis of acute, recent, or chronic hepatitis B Determination of chronic hepatitis B status Screening pregnant women for evidence of chronic hepatitis B (or hepatitis B carrier state) to identify neonates who are at high risk of...
RLTE4 - Overview: Leukotriene E4, Random, Urine
Aiding in the evaluation of patients at-risk for mast cell activation syndrome (eg, systemic mastocytosis, IgE-mediated allergies, or aspirin-exacerbated respiratory disease) using random urine collections
Information: Interpreting Laboratory Tests to Determine New vs. Residual Use of Marijuana - Insights
In this month's "Hot Topic," Paul Jannetto, Ph.D., identifies how to determine new vs. residual use of marijuana in a patient, and teaches how to calculate the carboxy-tetrahydrocannabinol (carboxy-THC)...
COVID-19: At-home sample collection vs. at-home testing - Insights
for COVID-19 sounds straightforward. But there's nuance to it that's important to understand. Right now, an at-home test for COVID-19 is not available, although there may be one coming soon. But in some...
Mayo Now Has Two Ninjas in the House - Insights
Candace Granberg, M.D., has a lot of titles, including surgeon, wife, mom, and volunteer. Now, she can add another: ninja warrior. The pediatric urologist is the second Mayo staff member chosen to participate...
The State of COVID-19 Now: Dr. Bill Morice - Insights
M.D. This week, Dr. Morice and Dr. Pritt step back and look at where the COVID-19 pandemic stands now, and they consider the potential effects that the omicron variant, expanded testing availability, and...
rights reserved. 07/2021 Hepatitis E: Testing Algorithm for Diagnosis and Management Immunocompetent patients with abnormal liver enzyme levels and at risk for hepatitis E virus (HEV) Immun......